Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 8× · first seen 09-sep-2026 · last seen 13-nov-2026

Urolithin A

Current understanding

To be populated as evidence accumulates.

Evidence log

Open questions

Related

Contributing findings

pubmed preclinical animal-model
Urolithin A plus EGCG enhances mitophagy associated pathways, mitochondrial dynamics, and bioenergetic function in humanized amyloid-β knock-in mice.
10-nov-2026 novelty 3 per-area 3 strengthens
pubmed review mechanism-plausible
Mitochondrial homeostasis in musculoskeletal diseases: From pathogenic mechanisms to precision therapies.
11-sep-2026 novelty 3 per-area 3 strengthens
clinicaltrials trial early expert-opinion
Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers
10-aug-2026 novelty 3 per-area 3 strengthens
pubmed review mechanism-plausible
Natural Bioactive Compounds Targeting Key Hallmarks of Aging: Functional Food Potential of Spermidine, Fisetin, Berberine, and Urolithin A.
03-aug-2026 novelty 3 per-area 3 strengthens
pubmed review
Senomorphic agents: Multi-target strategies to tame the senescence-associated secretory phenotype for healthy ageing.
24-jul-2026 novelty 2 per-area 2 strengthens
pubmed review mechanism-plausible
Is Urolithin A(UA) a pharmacologically credible neuro-nutraceutical? A critical review of mechanisms, brain exposure, and evidence gaps in Alzheimer's and Parkinson's disease.
17-jul-2026 novelty 3 per-area 3 strengthens
pubmed trial early expert-opinion
PROMETHEUS clinical trial protocol: tailoring healthy ageing with lifestyle and nutraceuticals.
03-jul-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
A 3-N nose-to-brain urolithin a nanomotor targeting microglial mitophagy in neuroinflammation.
03-apr-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18